Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease

Regulation of glutathione synthesis

Lu, S. C.-L. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.005 · Cited by 2,131 · see citing works

Selected reaction monitoring for quantitative proteomics: a tutorial

Lange, V., Picotti, P., Domon, B., & Aebersold, R. H. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.61 · Cited by 1,396 · see citing works

Detection of Chronic Kidney Disease With Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association With Progression to End-Stage Renal Disease and Mortality

Peralta, C. A. (2011) · JAMA · doi:10.1001/jama.2011.468 · Cited by 460 · see citing works

Biomarkers in chronic kidney disease: a review

Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 449 · see citing works

Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR

Phisitkul, S., Khanna, A., Simoni, J. M., Broglio, K. R., Sheather, S. J., Rajab, M. H., & Wesson, D. E. (2010) · Kidney International · doi:10.1038/ki.2009.519 · Cited by 287 · see citing works

Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis

Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk056 · Cited by 282 · see citing works

Metabolomics in the study of kidney diseases

Weiss, R. H., & Kim, K. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.152 · Cited by 265 · see citing works

Role of glutamine in human carbohydrate metabolism in kidney and other tissues

Stümvoll, M., Perriello, G., Meyer, C., & Gerich, J. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003778.x · Cited by 230 · see citing works

Human Urine as Test Material in 1H NMR-Based Metabonomics: Recommendations for Sample Preparation and Storage

Lauridsen, M. B., Hansen, S. H., Jaroszewski, J. W., & Cornett, C. (2007) · Analytical Chemistry · doi:10.1021/ac061354x · Cited by 179 · see citing works

Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion

Brusilow, S. W. (1991) · Pediatric Research · doi:10.1203/00006450-199102000-00009 · Cited by 173 · see citing works

Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)

van der Kloet, F. M., Tempels, F. W. A., Ismail, N., van der Heijden, R., Kasper, P. T., Rojas‐Chertó, M., van Doorn, R., Spijksma, G. K., Koek, M. M., van der Greef, J., et al. (2011) · Metabolomics · doi:10.1007/s11306-011-0291-6 · Cited by 159 · see citing works

Proteomics meets the scientific method

Picotti, P., Bodenmiller, B., & Aebersold, R. H. (2012) · Nature Methods · doi:10.1038/nmeth.2291 · Cited by 149 · see citing works

Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide

Bell, J. D., Lee, J. A., Lee, H. A., Sadler, P. J., Wilkie, D. R., & Woodham, R. H. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90046-c · Cited by 147 · see citing works

Plasma Metabolomic Profiles in Different Stages of CKD

Shah, V. O., Townsend, R. R., Feldman, H. I., Pappan, K. L., Kensicki, E., & Jagt, D. L. V. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05540512 · Cited by 113 · see citing works

A Pilot Metabolic Profiling Study in Serum of Patients with Chronic Kidney Disease Based on 1H‐NMR‐Spectroscopy

Qi, S., Ouyang, X., Wang, L., Peng, W., Wen, J., & Dai, Y. (2012) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2012.00437.x · Cited by 72 · see citing works

The Sudden Demise of Dual Renin-Angiotensin System Blockade or the Soft Science of the Surrogate End Point

Messerli, F. H. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.036 · Cited by 64 · see citing works

Sulphur amino acids in plasma and muscle in patients with chronic renal failure: evidence for taurine depletion

Bergström, J. P., Alvestrand, A., Fürst, P., & Lindholm, B. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb01378.x · Cited by 58 · see citing works

Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum

Gao, X., Chen, W.-J., Li, R., Wang, M., Chen, C., Zeng, R., & Deng, Y. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-s1-s14 · Cited by 52 · see citing works

Accumulation of taurine in patients with renal failure

Suliman, M. E., Barany, P. F., Filho, J. C. D., Lindholm, B., & Bergström, J. P. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.3.528 · Cited by 42 · see citing works

Application of proteomic analysis to the study of renal diseases

Smith, M. W., Banks, R. E., Wood, S. L., Lewington, A. J. P., & Selby, P. J. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.183 · Cited by 38 · see citing works

Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients.

Zimmerman, L., Egestad, B., Jörnvall, H., & Bergström, J. P. (1989) · PubMed · Cited by 21 · see citing works

Urinary Metabolomic Analysis for the Identification of Renal Injury in Patients With Acute Heart Failure

Diercks, D. B., Owen, K. P., Tolstikov, V., & Sutter, M. E. (2012) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2011.01239.x · Cited by 12 · see citing works

Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses

Thévenot, E., Roux, A., Xu, Y., Ezan, É., & Junot, C. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00354 · Cited by 1,757 · see citing works

Targeting metabolic dysregulation for fibrosis therapy

Zhao, X. L., Kwan, J. Y. Y., Yip, K. W., Liu, P. P., & Liu, F. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 516 · see citing works

Trimethylamine <i>N</i> -Oxide, the Microbiome, and Heart and Kidney Disease

Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475 · see citing works

The systemic nature of CKD

Zoccali, C., Vanholder, R. C., Massy, Z. A., Ortíz, A., Sarafidis, P. A., Dekker, F. W., Fliser, D., Fouque, D. P., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 464 · see citing works

Metabolomics for clinical use and research in chronic kidney disease

Hocher, B., & Adamski, J. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.30 · Cited by 335 · see citing works

Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

Chen, D., Cao, G., Chen, H., Argyopoulos, C. P., Yu, H., Su, W. C., Chen, L., Samuels, D. C., Zhuang, S., Bayliss, G. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09329-0 · Cited by 270 · see citing works

Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis

Ding, H., Jiang, L., Xu, J., Bai, F., Zhou, Y., Yuan, Q., Luo, J., Zen, K., & Yang, J. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00036.2017 · Cited by 250 · see citing works

Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression

Chen, H., Cao, G., Chen, D., Wang, M., Vaziri, N. D., Zhang, Z., Mao, J., Bai, X., & Zhao, Y. (2016) · Redox Biology · doi:10.1016/j.redox.2016.09.014 · Cited by 162 · see citing works

Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease

Chen, D., Cao, G., Chen, H., Liu, D., Su, W. C., Yu, X.-Y., Vaziri, N. D., Liu, X., Bai, X., Zhang, L., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.017 · Cited by 161 · see citing works

Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis

Zhang, Z., Wei, F., Vaziri, N. D., Cheng, X., Bai, X., Lin, R., & Zhao, Y. (2015) · Scientific Reports · doi:10.1038/srep14472 · Cited by 155 · see citing works

An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure

Zhang, Z., Vaziri, N. D., Wei, F., Cheng, X., Bai, X., & Zhao, Y. (2016) · Scientific Reports · doi:10.1038/srep22151 · Cited by 136 · see citing works

UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry

Zhao, Y., Cheng, X., Vaziri, N. D., Liu, S., & Lin, R. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.07.019 · Cited by 130 · see citing works

Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease

Fernández-Prado, R., Esteras, R., Pérez-Gómez, M., Gracia-Iguacel, C., González-Parra, E., Sanz, A., Ortiz, A., & Sánchez-Niño, M. (2017) · Nutrients · doi:10.3390/nu9050489 · Cited by 89 · see citing works

Assessment of Metabolomic and Proteomic Biomarkers in Detection and Prognosis of Progression of Renal Function in Chronic Kidney Disease

Nkuipou‐Kenfack, E., Duranton, F., Gayrard, N., Argilés, À., Lundin, U., Weinberger, K. M., Dakna, M., Delles, C., Mullen, W., Husi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096955 · Cited by 108 · see citing works

Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure

Zhao, F., Bergstralh, E. J., Mehta, R. A., Vaughan, L. E., Olson, J. B., Seide, B. M., Meek, A. M., Cogal, A. G., Lieske, J. C., & Milliner, D. S. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02810315 · Cited by 98 · see citing works

A review of validated biomarkers obtained through metabolomics

López-López, Á., López‐Gonzálvez, Á., Barker‐Tejeda, T. C., & Barbas, C. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1481391 · Cited by 94 · see citing works

Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer

Darshi, M., Espen, B. V., & Sharma, K. (2016) · American Journal of Nephrology · doi:10.1159/000447954 · Cited by 93 · see citing works

TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

Ye, Z., Lulu, C., Xiangchang, Z., Fang, Q., Binjie, Z., Chunyang, L., Rao, T., & Dongsheng, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929262 · Cited by 90 · see citing works

Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota

Pan, L., Yu, H., Fu, J., Hu, J., Xu, H. X., Zhang, Z., Bu, M.-M., Yang, X., Zhang, H., Lu, J., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.010 · Cited by 81 · see citing works

Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell–Mediated Rejection in Children After Kidney Transplantation

Blydt‐Hansen, T. D., Sharma, A., Gibson, I. W., Mandal, R., & Wishart, D. S. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12837 · Cited by 81 · see citing works

Chronic kidney disease and kidney stones

Uribarri, J. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000582 · Cited by 78 · see citing works

Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition

Lee, J., Lee, J., Kim, K., Lee, J., Jung, Y., Hyeon, J. S., Seo, A., Jin, W., Weon, B., Shin, N., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.01.040 · Cited by 76 · see citing works

Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes

Zhang, Y., Liang, F., Zhang, D., Qi, S., & Liu, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114046 · Cited by 74 · see citing works

biosigner: A New Method for the Discovery of Significant Molecular Signatures from Omics Data

Rinaudo, P., Boudah, S., Junot, C., & Thévenot, E. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00026 · Cited by 74 · see citing works

Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes

Mutter, S., Valo, E., Aittomäki, V., Nybo, K., Raivonen, L., Thorn, L. M., Forsblom, C. M., Sandholm, N., Würtz, P., & Groop, P. (2021) · Diabetologia · doi:10.1007/s00125-021-05584-3 · Cited by 69 · see citing works

Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease

Cañadas‐Garre, M., Anderson, K., McGoldrick, J., Maxwell, A. P., & McKnight, A. J. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.09.020 · Cited by 66 · see citing works

Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease

Hsu, C., Chang‐Chien, G., Lin, S., Hou, C., Lu, P., & Tain, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020336 · Cited by 66 · see citing works

Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis

Tamura, M. K., Chertow, G. M., Depner, T. A., Nissenson, A. R., Schiller, B. M., Mehta, R. L., Liu, S., Sirich, T. L., & Study, O. B. O. T. F. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016010039 · Cited by 64 · see citing works

Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer

Liang, Q., Wang, C., & Li, B. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1706-z · Cited by 61 · see citing works

Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids

Wu, C., Duan, J., Liu, T., Smith, R. D., & Qian, W. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.01.015 · Cited by 59 · see citing works

Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate

Gil, R., Ortíz, A., Sánchez-Niño, M. D., Markoska, K., Schepers, E., Vanholder, R. C., Glorieux, G., Schmitt‐Kopplin, P., & Heinzmann, S. S. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy020 · Cited by 56 · see citing works

Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan

Hyeon, J. S., Jung, Y., Lee, G.-Y., Ha, H., & Hwang, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238969 · Cited by 52 · see citing works

Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers

Dhayat, N. A., Gradwell, M. W., Pathare, G., Anderegg, M. A., Schneider, L., Luethi, D., Mattmann, C., Moe, O. W., Vogt, B., & Fuster, D. G. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01320217 · Cited by 52 · see citing works

Citric Acid Metabolism in Resistant Hypertension

Martin‐Lorenzo, M., Martínez, P. J., Martin, M. B., Ruiz‐Hurtado, G., Prado, J. C., Segura, J., de la Cuesta, F., Barderas, M. G., Vivanco, F., Ruilope, L. M., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09819 · Cited by 51 · see citing works

KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery

Martin‐Lorenzo, M., Zubiri, I., Maroto, A. S., Gonzalez‐Calero, L., Posada-Ayala, M., de la Cuesta, F., Mouriño-Álvarez, L., Lopez-Almodovar, L. F., Calvo‐Bonacho, E., Ruilope, L. M., et al. (2014) · Metabolomics · doi:10.1007/s11306-014-0761-8 · Cited by 49 · see citing works

Metabolomics and renal disease

Rhee, E. P. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000136 · Cited by 49 · see citing works

Blood, urine and faecal metabolite profiles in the study of adult renal disease

Barrios, C., Spector, T. D., & Menni, C. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.10.006 · Cited by 48 · see citing works

Combination use of medicines from two classes of renin–angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function

Esteras, R., Pérez-Gómez, M. V., Rodríguez-Osorio, L., Ortíz, A., & Fernández‐Fernández, B. (2015) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098615589905 · Cited by 48 · see citing works

Application of metabolomics in urolithiasis: the discovery and usage of succinate

Zhang, X., Lei, X., Jiang, Y., Zhao, L.-M., Zou, C., Bai, Y., Li, Y., Wang, R., Li, Q., Chen, Q.-Z., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01311-z · Cited by 45 · see citing works

Biomarkers in Transplantation—Proteomics and Metabolomics

Christians, U., Klawitter, J., & Klawitter, J. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000243 · Cited by 44 · see citing works

Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats

Ji, C., Yin, L., Mo, Y., Lu, Z., Lu, F., Lin, Q., Liu, X., Zou, C., & Wu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.780924 · Cited by 41 · see citing works

Metabolite Profiling of Feces and Serum in Hemodialysis Patients and the Effect of Medicinal Charcoal Tablets

Liu, S., Liang, S., Liu, H., Chen, L., Sun, L., Wei, M., Jiang, H., & Wang, J. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000489912 · Cited by 41 · see citing works

Urine metabolomics insight into acute kidney injury point to oxidative stress disruptions in energy generation and H2S availability

Martin‐Lorenzo, M., Gonzalez‐Calero, L., Ramos-Barron, M. A., Sánchez-Niño, M. D., Gómez-Alamillo, C., García-Segura, J. M., Ortíz, A., Arias, M., Vivanco, F., & Álvarez‐Llamas, G. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1594-5 · Cited by 41 · see citing works

Urinary proteome and metabolome in dogs (Canis lupus familiaris): The effect of chronic kidney disease

Ferlizza, E., Isani, G., Dondi, F., Andreani, G., Vasylyeva, K., Bellei, E., de Almeida, A. M., & Matzapetákis, M. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103795 · Cited by 41 · see citing works

A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cells

Liu, C., Wang, X., Wang, X., Zhang, Y., Min, W., Yu, P., Miao, J., Shen, W., Chen, S., Zhou, S. Y., et al. (2022) · Theranostics · doi:10.7150/thno.78376 · Cited by 40 · see citing works

Cytoskeleton deregulation and impairment in amino acids and energy metabolism in early atherosclerosis at aortic tissue with reflection in plasma

Martin‐Lorenzo, M., Gonzalez‐Calero, L., Maroto, A. S., Martínez, P. J., Zubiri, I., de la Cuesta, F., Mouriño-Álvarez, L., Barderas, M. G., Heredero, A., Aldámiz‐Echevarría, G., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.006 · Cited by 39 · see citing works

Biomarkers of obstructive nephropathy using a metabolomics approach in rat

Zhang, Z., He, J., Qin, W., Zhao, Y., & Tan, N. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.10.004 · Cited by 39 · see citing works

Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5/6 nephrectomy rat model

Hanifa, M. A., Skott, M., Maltesen, R. G., Rasmussen, B. S., Nielsen, S. U., Frøkiær, J., Ring, T., & Wimmer, R. (2019) · Metabolomics · doi:10.1007/s11306-019-1569-3 · Cited by 39 · see citing works

A capillary electrophoresis coupled to mass spectrometry pipeline for long term comparable assessment of the urinary metabolome

Boizard, F., Brunchault, V., Moulos, P., Breuil, B., Klein, J., Lounis, N., Caubet, C., Tellier, S., Bascands, J., Decramer, S., et al. (2016) · Scientific Reports · doi:10.1038/srep34453 · Cited by 38 · see citing works

Hypertensive patients exhibit an altered metabolism. A specific metabolite signature in urine is able to predict albuminuria progression

Gonzalez‐Calero, L., Martin‐Lorenzo, M., Martínez, P. J., Martin, M. B., Ruiz‐Hurtado, G., Segura, J., de la Cuesta, F., Barderas, M. G., Ruilope, L. M., Vivanco, F., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.003 · Cited by 37 · see citing works

Distinct urine metabolome after Asian ginseng and American ginseng intervention based on GC-MS metabolomics approach

Liu, Y., Yu, Q., Ge, Y., Zhang, W.-S., Fan, Y., Ma, C., Liu, Q., & Qi, L. (2016) · Scientific Reports · doi:10.1038/srep39045 · Cited by 37 · see citing works

Urinary Metabolomics for Noninvasive Detection of Antibody-Mediated Rejection in Children After Kidney Transplantation

Blydt‐Hansen, T. D., Sharma, A., Gibson, I. W., Wishart, D. S., Mandal, R., Ho, J., Nickerson, P. W., & Rush, D. N. (2017) · Transplantation · doi:10.1097/tp.0000000000001662 · Cited by 37 · see citing works

Untargeted metabolomics for plasma biomarker discovery for early chronic kidney disease diagnosis in pediatric patients using LC-QTOF-MS

Cid, S. B., Sánchez‐Ortega, A., Unceta, N., Andrade, F., Aldamiz-Echevarria, L. J., Goicolea, M. A., & Barrio, R. J. (2018) · The Analyst · doi:10.1039/c8an00864g · Cited by 37 · see citing works

Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy

Tan, Y. M., Gao, Y., Teo, G., Koh, H. W. L., Tai, E. S., Khoo, C. M., Choi, K. P., Zhou, L., & Choi, H. (2021) · Metabolites · doi:10.3390/metabo11040228 · Cited by 37 · see citing works

Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry: a pilot study

Boelaert, J., Lynen, F., Glorieux, G., Schepers, E., Neirynck, N., & Vanholder, R. C. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0165-x · Cited by 35 · see citing works

Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes

Lee, J., Choi, J., Kwon, Y., Lee, D., Jung, H., Ryu, H., Cho, J., Ryu, D. H., Kim, Y.-L., & Hwang, G. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.018 · Cited by 35 · see citing works

Metabolomics in chronic kidney disease: Strategies for extended metabolome coverage

Gagnebin, Y., Boccard, J., Ponte, B., & Rudaz, S. L. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.08.046 · Cited by 35 · see citing works

Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis

Øvrehus, M. A., Bruheim, P., Ju, W., Zelnick, L. R., Langlo, K. A. R., Sharma, K., de Boer, I. H., & Hallan, S. I. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.10.007 · Cited by 34 · see citing works

Metabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid

Perales-Quintana, M. M., Saucedo, A. L., Lucio-Gutiérrez, J. R., de Torres, N. H. W., Alarcón-Galván, G., Govea-Torres, G., Sánchez‐Martínez, C., Pérez‐Rodríguez, E., Garza, F., & Cordero‐Pérez, P. (2019) · PeerJ · doi:10.7717/peerj.7113 · Cited by 34 · see citing works

Identification of metabolites from 2D 1H-13C HSQC NMR using peak correlation plots

Öman, T., Tessem, M., Bathen, T. F., Bertilsson, H., Angelsen, A., Hedenström, M., & Andreassen, T. (2014) · BMC Bioinformatics · doi:10.1186/s12859-014-0413-z · Cited by 34 · see citing works

Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis?

Gonzalez‐Calero, L., Martin‐Lorenzo, M., Ramos-Barron, M. A., Ruiz-Criado, J., Maroto, A. S., Ortíz, A., Gómez-Alamillo, C., Arias, M., Vivanco, F., & Álvarez‐Llamas, G. (2016) · Scientific Reports · doi:10.1038/srep19667 · Cited by 34 · see citing works

Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights

Song, Y., Wei, H., Zhou, Z., Wang, H., Hang, W., Wu, J., & Wang, D. W. (2024) · Frontiers of Medicine · doi:10.1007/s11684-024-1055-9 · Cited by 32 · see citing works

Analysis of urinary exosomal metabolites identifies cardiovascular risk signatures with added value to urine analysis

Agudiez, M., Martínez, P. J., Martin‐Lorenzo, M., Heredero, A., Santiago‐Hernandez, A., Molero, D., García-Segura, J. M., Aldámiz‐Echevarría, G., & Álvarez‐Llamas, G. (2020) · BMC Biology · doi:10.1186/s12915-020-00924-y · Cited by 32 · see citing works

An Update of Urine and Blood Metabolomics in Chronic Kidney Disease

Kalantari, S., & Nafar, M. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0008 · Cited by 31 · see citing works

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression

Gonzalez‐Calero, L., Martin‐Lorenzo, M., de la Cuesta, F., Maroto, A. S., Martin, M. B., Ruiz‐Hurtado, G., Pulido-Olmo, H., Segura, J., Barderas, M. G., Ruilope, L. M., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0331-7 · Cited by 30 · see citing works

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

Kwon, S., Hyeon, J. S., Jung, Y., Li, L., An, J. N., Kim, Y. C., Yang, S. H., Kim, T., Kim, D. K., Lim, C. S., et al. (2023) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.22.152 · Cited by 28 · see citing works

Renal function is associated with plasma trimethylamine-N-oxide, choline, l-carnitine and betaine: a pilot study

Guo, F., Dai, Q., Zeng, X., Liu, Y., Tan, Z., Zhang, H., & Ouyang, D. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02632-6 · Cited by 26 · see citing works

A Novel Metabolic Signature To Predict the Requirement of Dialysis or Renal Transplantation in Patients with Chronic Kidney Disease

Zacharias, H. U., Altenbuchinger, M., Schultheiß, U. T., Samol, C., Kotsis, F., Poguntke, I., Sekula, P., Krumsiek, J., Köttgen, A., Spang, R., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00983 · Cited by 24 · see citing works

Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data

Luck, M. M., Bertho, G., Bateson, M., Karras, A., Yartseva, A., Thervet, É., Damon, C., & Pallet, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166905 · Cited by 24 · see citing works

Plant Metabolomics: The Future of Anticancer Drug Discovery

Dabbousy, R., Rima, M., Roufayel, R., Rahal, M. K., Legros, C., Sabatier, J., & Fajloun, Z. (2024) · Pharmaceuticals · doi:10.3390/ph17101307 · Cited by 23 · see citing works

Non‐invasive staging of chronic kidney allograft damage using urine metabolomic profiling

Landsberg, A., Sharma, A., Gibson, I. W., Rush, D. N., Wishart, D. S., & Blydt‐Hansen, T. D. (2018) · Pediatric Transplantation · doi:10.1111/petr.13226 · Cited by 23 · see citing works

Identification of a urine metabolite constellation characteristic for kidney allograft rejection

Banas, M., Neumann, S., Eiglsperger, J., Schiffer, E., Putz, F. J., Reichelt‐Wurm, S., Krämer, B. K., Pagel, P., & Banas, B. (2018) · Metabolomics · doi:10.1007/s11306-018-1419-8 · Cited by 23 · see citing works

Metabonomic biomarkers for risk factors of chronic kidney disease

Ye, L., & Mao, W. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1239-6 · Cited by 22 · see citing works

Combined Untargeted and Targeted Metabolomics Approaches Reveal Urinary Changes of Amino Acids and Energy Metabolism in Canine Babesiosis With Different Levels of Kidney Function

Kuleš, J., Rubić, I., Ljubić, B. B., Bilić, P., Rafaj, R. B., Brkljačić, M., Burchmore, R., Eckersall, P. D., & Mrljak, V. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.715701 · Cited by 21 · see citing works

Early detection of unilateral ureteral obstruction by desorption electrospray ionization mass spectrometry

Banerjee, S., Wong, A. C.-Y., Yan, X., Wu, B., Zhao, H., Tibshirani, R. J., Zare, R. N., & Brooks, J. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-47396-x · Cited by 21 · see citing works

Urinary Biomarkers of Renal Fibrosis

Zhou, L., Lv, L., & Liu, B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_30 · Cited by 20 · see citing works

Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review

Das, S., Rajeswari, V. D., Venkatraman, G., Elumalai, R., Sivaraman, D., & Ramanathan, G. (2023) · Translational research · doi:10.1016/j.trsl.2023.11.002 · Cited by 20 · see citing works

Metabolomics of Interstitial Fluid, Plasma and Urine in Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms

Chachaj, A., Matkowski, R., Gröbner, G., Szuba, A., & Dudka, I. (2020) · Diagnostics · doi:10.3390/diagnostics10110936 · Cited by 20 · see citing works

The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease

Pan, S., Zhao, D., Duan, S., & Chen, X. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03500-9 · Cited by 20 · see citing works

The influence of a chronic L‐carnitine administration on the plasma metabolome of male Fischer 344 rats*

Weinert, C. H., Empl, M. T., Krüger, R., Frommherz, L., Egert, B., Steinberg, P., & Kulling, S. E. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600651 · Cited by 19 · see citing works

Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease

Kordalewska, M., Macioszek, S., Wawrzyniak, R., Sikorska-Wiśniewska, M., Śledziński, T., Chmielewski, M. S., Mika, A., & Markuszewski, M. J. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.04.003 · Cited by 19 · see citing works

Metabolomic Analysis of Membranous Glomerulonephritis: Identification of a Diagnostic Panel and Pathogenic Pathways

Taherkhani, A., Nafar, M., Oskouie, A. A., Broumandnia, N., Parvin, M., Mahmoudieh, L., & Kalantari, S. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.004 · Cited by 19 · see citing works

Monitoring of the influence of long‐term oxidative stress and ischemia on the condition of kidneys using solid‐phase microextraction chemical biopsy coupled with liquid chromatography–high‐resolution mass spectrometry

Stryjak, I., Warmuzińska, N., Bogusiewicz, J., Łuczykowski, K., & Bojko, B. (2020) · Journal of Separation Science · doi:10.1002/jssc.202000032 · Cited by 18 · see citing works

Nmr Metabolomics of Renal Cancer: an Overview

Gil, A. M., de Pinho, P. G., Monteiro, M. S., & Duarte, I. F. (2015) · Bioanalysis · doi:10.4155/bio.15.167 · Cited by 17 · see citing works

Serum Metabolites and Kidney Outcomes: The Atherosclerosis Risk in Communities Study

Bernard, L., Zhou, L., Surapaneni, A., Chen, J., Rebholz, C. M., Coresh, J., Yu, B., Boerwinkle, E., Schlosser, P., & Grams, M. E. (2022) · Kidney Medicine · doi:10.1016/j.xkme.2022.100522 · Cited by 17 · see citing works

Urine-Based Detection of Biomarkers Indicative of Chronic Kidney Disease in a Patient Cohort from Ghana

Wruck, W., Boima, V., Erichsen, L., Thimm, C., Koranteng, T., Kwakyi, E. P. K., Antwi, S., Adu, D., & Adjaye, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm13010038 · Cited by 16 · see citing works

Might hyperbaric oxygen therapy (HBOT) reduce renal injury in diabetic people with diabetes mellitus? From preclinical models to human metabolomics

Harrison, L. E., Giardina, C. A., Hightower, L. E., Anderson, C. A., & Perdrizet, G. A. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-018-0944-8 · Cited by 16 · see citing works

New Insights from Metabolomics in Pediatric Renal Diseases

Riccio, S., Valentino, M. S., Passaro, A. P., Izzo, M., Guarino, S., del Giudice, E. M., Marzuillo, P., & Sessa, A. D. (2022) · Children · doi:10.3390/children9010118 · Cited by 15 · see citing works

Metabolomics and molecular dynamics unveil the therapeutic potential of epalrestat in diabetic nephropathy

Song, T., Wang, R., Zhou, X., Chen, W., Chen, Y., Liu, Z., & Men, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112812 · Cited by 15 · see citing works

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria

Martin‐Lorenzo, M., Gonzalez‐Calero, L., Martínez, P. J., Martin, M. B., López, J. A., Ruiz‐Hurtado, G., de la Cuesta, F., Segura, J., Vázquez, J., Vivanco, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09042-2 · Cited by 15 · see citing works

Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations

Martínez, P. J., Agudiez, M., Molero, D., Martin‐Lorenzo, M., Martin, M. B., Santiago‐Hernandez, A., García-Segura, J. M., Madruga, F., Cabrera, M., Calvo, E., et al. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01976-x · Cited by 15 · see citing works

Urinary Metabolite Profile Predicting the Progression of CKD

Kim, Y., Lee, J., Kang, M. S., Song, J., Kim, S. G., Cho, S., Huh, H., Lee, S., Park, S., Jo, H. A., et al. (2023) · Kidney360 · doi:10.34067/kid.0000000000000158 · Cited by 14 · see citing works

Hyperpolarized 13C NMR Metabolomics of Urine Samples at Natural Abundance Applied to Chronic Kidney Disease

Ribay, V., Charrier, B., Croyal, M., Cariou, B., Hadjadj, S., Boccard, J., Cannet, C., Dumez, J., Letertre, M. P. M., & Giraudeau, P. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c12607 · Cited by 14 · see citing works

TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension

Santiago‐Hernandez, A., Martin‐Lorenzo, M., Martín-Blázquez, A., Ruiz‐Hurtado, G., Barderas, M. G., Segura, J., Ruilope, L. M., & Álvarez‐Llamas, G. (2021) · Antioxidants · doi:10.3390/antiox10071100 · Cited by 14 · see citing works

Urinary non-targeted toxicokinetics and metabolic fingerprinting of exposure to 3-monochloropropane-1,2-diol and glycidol from refined edible oils

Jia, W. P., Zhuang, P., Wang, Q., Wan, X., Mao, L., Chen, X., Miao, H., Chen, D., Ren, Y., & Zhang, Y. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110898 · Cited by 14 · see citing works

Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction

Zou, J., Zhou, X., Chen, X., Ma, Y., & Yu, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849832 · Cited by 13 · see citing works

The Role of Metabolomics in the Study of Kidney Diseases and in the Development of Diagnostic Tools

Christians, U., Albuisson, J., Klawitter, J., & Klawitter, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375672-5.10003-9 · Cited by 13 · see citing works

Metabolomics insights into diabetes nephropathy and protective effects of Radix Scutellariae on rats using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry

Men, L., Pi, Z., Zhou, Y., Liu, Y. Y., Wei, M., Song, F., & Liu, Z. (2017) · RSC Advances · doi:10.1039/c6ra28595c · Cited by 13 · see citing works

Urinary Microbiota and Serum Metabolite Analysis in Patients with Diabetic Kidney Disease

Yang, Y. H., Ma, C., Li, S., Cai, W., Dai, W., Zhang, X., Yin, L., Tang, D., Liu, F., & Dai, Y. (2022) · Heliyon · doi:10.1016/j.heliyon.2023.e17040 · Cited by 12 · see citing works

Berry fruits modulate kidney dysfunction and urine metabolome in Dahl salt-sensitive rats

Gomes, A., Godinho-Pereira, J., Oudot, C., Sequeira, C. O., Macià, A., Carvalho, F. D., Motilva, M., Pereira, S. A., Matzapetákis, M., Brenner, C., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.05.002 · Cited by 12 · see citing works

The Authors Reply:

Álvarez‐Llamas, G., Vivanco, F., & Ortíz, A. (2014) · Kidney International · doi:10.1038/ki.2014.39

FP367Significant urinary metabolites in the progression of chronic kidney disease

Kim, Y., Lee, S., Park, S., Lee, J. P., Joo, K. W., Lim, C. S., Kim, J. H., & Kim, D. K. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz106.fp367

Identification of novel serum metabolic signatures to predict chronic kidney disease among Chinese elders using UPLC-Orbitrap-MS

Liu, Y., Sun, M., Sun, J., Lin, F. Y., Xu, D., Chen, Y., Song, W., Li, Q., Jiang, Y., Gu, J., et al. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2023.100036 · Cited by 3 · see citing works

The urinary metabolome of chronic kidney disease

Pallet, N., Thervet, É., Beaune, P. H., Karras, A., & Bertho, G. (2014) · Kidney International · doi:10.1038/ki.2014.34 · Cited by 9 · see citing works

Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate

Gil, R., Ortíz, A., Sánchez-Niño, M. D., Markoska, K., Schepers, E., Vanholder, R. C., Glorieux, G., Schmitt‐Kopplin, P., & Heinzmann, S. S. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy020 · Cited by 56 · see citing works